| Application no. and date | 13776720.8 (espacenet) (Federated) (European Patent Register), 20131004 | | Patent/reg. no. and date | DK/EP 2914264, 20170809 | | Publication date | 20150909 | | Priority no. and date | EP 12007494, 20121102 | | EP pub. no. and date |
EP 2914264 20150909 | | Effective date | | | Applicant/owner | Merck Patent GmbH, Frankfurter Strasse 250
64293 Darmstadt, DE | | Applicant ref. no. | P62211DK01 | | Inventor | BLADT, Friedhelm, Werderstrasse 36
69120 Heidelberg, DE,
FRIESE-HAMIM, Manja, Stockhausenstrasse 1
64546 Moerfelden-Walldorf, DE | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 35/00 (2006.01) | | Title | 6-OXO-1,6-DIHYDRO-PYRIDAZINDERIVAT TIL ANVENDELSEN TIL BEHANDLINGEN AF HEPATOCELLULÆRT CARCINOM (HCC) | | Int. application no. | EP2013002998 | | Int. publication no. | WO2014067610 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
